Transcatheter Pulmonary Valve Replacement
- 10 Downloads
Percutaneous pulmonary valve implantation (PPVI) has the distinction of being the first percutaneous valve replacement in humans, writing a new chapter in cardiac therapeutics with the development of transcatheter valve technologies. This innovation has evolved as an attractive alternative to surgery and has allowed treatment of a growing patient population with congenital heart disease, minimizing the number of lifetime sternotomies and extending the life of previously implanted conduits. Since the introduction of this technology in 2000, several clinical trials have demonstrated effective restoration of valvular competence with excellent outcomes; transforming this technology from its early pioneering nature into routine clinical care at specialized centers.
KeywordsMelody® valve Percutaneous pulmonary valve implantation Pulmonary regurgitation Right ventricular outflow tract Transcatheter pulmonary valve replacement